Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-01-24 @ 6:16 AM
Study NCT ID:
NCT01727869
Status:
COMPLETED
Last Update Posted:
2015-04-06
First Post:
2012-11-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
Keywords: